- Home
- Publications
- Publication Search
- Publication Details
Title
Leukemic stem cells: identification and clinical application
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 105, Issue 5, Pages 549-557
Publisher
Springer Nature
Online
2017-03-29
DOI
10.1007/s12185-017-2221-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DOT1L as a therapeutic target for the treatment of DNMT3A -mutant acute myeloid leukemia
- (2016) Rachel E. Rau et al. BLOOD
- Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
- (2016) T.-C. Ho et al. BLOOD
- CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia
- (2016) Bas Kersten et al. BRITISH JOURNAL OF HAEMATOLOGY
- Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells
- (2016) Nobuaki Fukushima et al. CANCER SCIENCE
- The hematopoietic stem-cell niche in health and leukemia
- (2016) Abel Sánchez-Aguilera et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma
- (2016) Federica Barbieri et al. Expert Opinion on Drug Discovery
- The optimal dosing of gemtuzumab ozagamicin: where to go from here?
- (2016) T. de Witte et al. HAEMATOLOGICA
- Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy
- (2016) S Z Gadhoum et al. LEUKEMIA
- KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells
- (2016) J Etchin et al. LEUKEMIA
- Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia
- (2016) N Khan et al. LEUKEMIA
- A gene-expression profile for leukaemia
- (2016) Gerrit J. Schuurhuis NATURE
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
- (2016) Sheng Li et al. NATURE MEDICINE
- Therapeutic targeting of splicing in cancer
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- Assessment of Minimal Residual Disease in Standard-Risk AML
- (2016) Adam Ivey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
- (2016) G Venton et al. Blood Cancer Journal
- The optimal dosing of gemtuzumab ozagamicin: where to go from here?
- (2016) T. de Witte et al. HAEMATOLOGICA
- Advances in Antibody Design
- (2015) Kathryn E. Tiller et al. Annual Review of Biomedical Engineering
- Stem cell niche as a prognostic factor in leukemia
- (2015) Ga-Young Lee et al. BMB Reports
- Absence of leukaemic CD34+cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered
- (2015) Wendelien Zeijlemaker et al. BRITISH JOURNAL OF HAEMATOLOGY
- An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38lowblasts
- (2015) Naeem Khan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effective targeting of primitive AML CD34+cells by the second-generation proteasome inhibitor carfilzomib
- (2015) Lieke H. van der Helm et al. BRITISH JOURNAL OF HAEMATOLOGY
- A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
- (2015) Yin Li et al. CURRENT CANCER DRUG TARGETS
- Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells
- (2015) Lina Han et al. CYTOMETRY PART A
- The rarity of ALDH+cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients
- (2015) Van T. Hoang et al. INTERNATIONAL JOURNAL OF CANCER
- Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia
- (2015) Jeffery M. Klco et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- New drug approvals in acute myeloid leukemia: what’s the best end point?
- (2015) E Estey et al. LEUKEMIA
- Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice
- (2015) J Etchin et al. LEUKEMIA
- Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia
- (2015) W Zeijlemaker et al. LEUKEMIA
- Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia
- (2015) Yoshikane Kikushige et al. ONCOLOGY
- Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
- (2015) Helena Ågerstam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clonal Evolution Enhances Leukemia-Propagating Cell Frequency in T Cell Acute Lymphoblastic Leukemia through Akt/mTORC1 Pathway Activation
- (2014) Jessica S. Blackburn et al. CANCER CELL
- Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance
- (2014) Anna Wojtuszkiewicz et al. Expert Opinion on Drug Metabolism & Toxicology
- Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
- (2014) Yuki Kagoya et al. JOURNAL OF CLINICAL INVESTIGATION
- Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
- (2014) Monique Terwijn et al. PLoS One
- Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
- (2014) A Ehninger et al. Blood Cancer Journal
- Selective killing of candidate AML stem cells by antibody targeting of IL1RAP
- (2013) M. Askmyr et al. BLOOD
- Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
- (2013) J. Kronke et al. BLOOD
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia
- (2013) Sylvie D. Freeman et al. JOURNAL OF CLINICAL ONCOLOGY
- High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
- (2013) Monique Terwijn et al. JOURNAL OF CLINICAL ONCOLOGY
- CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation
- (2013) Hong-Hu Zhu et al. LEUKEMIA RESEARCH
- Normal Hematopoietic Stem Cells within the AML Bone Marrow Have a Distinct and Higher ALDH Activity Level than Co-Existing Leukemic Stem Cells
- (2013) Gerrit J. Schuurhuis et al. PLoS One
- A clinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
- (2012) J. M. Gerber et al. BLOOD
- Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia
- (2012) B. Parkin et al. BLOOD
- Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
- (2012) L. Barreyro et al. BLOOD
- Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment
- (2012) Z. Zeng et al. BLOOD
- BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
- (2012) M. R. Kuhne et al. CLINICAL CANCER RESEARCH
- DyeCycle violet used for side population detection is a substrate of P-glycoprotein
- (2012) Maximilian Boesch et al. CYTOMETRY PART A
- The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse
- (2012) C Bachas et al. LEUKEMIA
- The proportion of CD34+CD38low or neg myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia
- (2012) M Roshal et al. LEUKEMIA
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
- (2011) Marina Y. Konopleva et al. JOURNAL OF CLINICAL ONCOLOGY
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- High Proportion of Leukemic Stem Cells at Diagnosis Is Correlated with Unfavorable Prognosis in Childhood Acute Myeloid Leukemia
- (2011) Kai-Erik Witte et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
- (2010) D. C. Taussig et al. BLOOD
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice
- (2010) Jean-Emmanuel Sarry et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
- (2010) Y. Saito et al. Science Translational Medicine
- Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia
- (2009) M Jawad et al. LEUKEMIA
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Identification of a Small Subpopulation of Candidate Leukemia-Initiating Cells in the Side Population of Patients with Acute Myeloid Leukemia
- (2008) Bijan Moshaver et al. STEM CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now